Publications

Mwai L, Musundi S, Waweru H, ... Kanoi BN*

Exploring the P. falciparum antigens associated with reduced risk of malaria in pregnancy

Frontiers in Immunology. 2025;16:1622435 (In press)

Kanoi BN*, Waweru H, Kobia F, Mukala J, Kirira P, Mogere D, Gallini R, ...

Plasma protein biomarkers of Plasmodium falciparum infection in pregnant women: a high-throughput proteomics study

Frontiers in Cellular and Infection Microbiology. 2025;15:1594088 (In press)

Yuguchi T, Dankyi BO, Rojrung R, Nagaoka H, Kanoi BN, Tiono AB, Nebie I, Ouedraogo A, Miura K, Sattabongkot J, Sirima SB.

Antibody responses in Burkinabe children against P. falciparum proteins associated with reduced risk of clinical malaria.

Frontiers in Immunology. 2025;16:1521082

Owino F, Kijogi C, Anzala O, Edwin W, Obiero J, Nyanjom SG, Eric AL, Kanoi BN, Gitaka J.

Placental Malaria Infection is Associated with Down regulation of STAT-6 and ANG-1 in Decidual Macrophages.

Frontiers in Immunology. 2025;16:1497936

Rotich AK, Mbogo K, Adamba P, Takashima E, Gitaka J, Kanoi BN*.

Targeting Plasmodium falciparum chondroitin sulfate a ligand: A highly conserved malaria antigen with potential for pregnancy-associated malaria vaccine development.

Open Research Europe. 2025 Jan 14;5(7):7

Nyirenda M, Kanoi BN, Omondi M, Nyanjom SG, Ochola L.

Evaluating the potential of Schistosoma mansoni Soluble Egg Antigen (SEA) and Glycoproteins (IPSE and Omega-1) in Inhibiting the Progression of Type 1 Diabetes.

F1000Research. 2025 Jun 10;14:576

Ochola L, Gitaka J, Kanoi B., Kimani CN, Akala HA, Alfred MO, Ochola-Oyier LI, Ogutu B.

Malaria Chemotherapeutics What Next for Africa.

Adv. Therap. 2025, 2400453

Ko YK, Gitaka J, Kanoi BN, Ngasala B, Kanamori M, Kagaya W, Kaneko A.

Previously undiagnosed disease “X” in the Democratic Republic of the Congo: malaria’s potential role in the outbreak.

Open Forum Infectious Diseases. 2025 Apr 18;12(5):ofaf240

Njaramba VW, David Kamau D, Mwaura P, Mungai S, Kanoi BN, Gitaka J.

Impact of home-based follow-up care on hypertension control among patients attending Thika Level Five Hospital, Kiambu County, Kenya: A randomized control study.

International Health. 2025 Apr 25:ihaf044

Mutua MM, Kanoi BN, Nyanjom SG, Musundi S, Makau M, Inoue S, Khamadi SA, Gitaka J, Wandera EA.

Development of Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Protein for COVID-19 Antigen Detection.

Research Square (preprint)

Ongaya A, Cardenas AR, Shiluli C, Ramos LB, Senador LC, Flores JA, Kanoi BN, Reijneveld JF, Ruvalcaba A, Perez D, Waiganjo P.

Prevalence of Long COVID in Mycobacterium tuberculosis-exposed Groups in Peru and Kenya.

medRxiv. 2025 Apr 29:2025-04

Shiluli C, Kamath S, Kanoi BN, Kimani R, Oduor B, Abkallo H, Maina M, Waweru H, Kamita M, Pamme N, Dupaty J.

Highly sensitive molecular assay based on Identical Multi-Repeat Sequence (IMRS) algorithm for the detection of Trichomonas vaginalis infection.

PloS One. 2025 Feb 7;20(2):e0317958

Ko YK, Kagaya W, Yoneoka D, Kongere J, Opiyo V, Oginga J, Omondi P, Musyoka KB, Chan CW, Kanoi BN, Gitaka J.

Where is the hard-to-reach population? Spatial analysis from a cross-sectional study on the access to bed net and malaria vaccine in the Lake Victoria Region, Kenya.

Malaria Journal. 2025 Feb 12;24:42

Ko YK, Kagaya W, Omondi P, Musyoka KB, Okai T, Chan CW, Kongere J, Opiyo V, Oginga J, Mungai S, Kanoi BN.

Evaluation of the protective efficacy of OlysetPlus ceiling nets for reduction of malaria incidence in children in Homa Bay County, Kenya: a cluster-randomised controlled study protocol.

BMJ Open. 2025 Jan 1;15(1):e087832